MEREDITH GRZYBOWSKI: Open Payments
NPI 1609202399 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 16 payments from 7 companies in 2025. Trend: 2023 $570 · 2024 $517 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $434 |
| Ipsen Biopharmaceuticals, Inc | 1 | $144 |
| ABBVIE INC. | 6 | $136 |
| Novo Nordisk Inc | 1 | $65 |
| Ardelyx, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: REZDIFFRA, IQIRVO, Wegovy, CREON, RINVOQ, IBSRELA, MAVYRET, LINZESS.
Industry payments across VA — which companies pay providers there.
